Is anyone watching the OSI/ Astellas situation? Even before today's positive CHMP opinion for Tarceva in first line maintenance therapy, OSI seemed to be looking for at least $70. My thoughts, such as they are, are here:
But I will add that the implied volatility of the options is currently very low. Which implies the Street doesn't think they'll get much more than $60. So just watching for now.